EP1453435A2 - Composition thermopolymere et procedes associes - Google Patents

Composition thermopolymere et procedes associes

Info

Publication number
EP1453435A2
EP1453435A2 EP02784553A EP02784553A EP1453435A2 EP 1453435 A2 EP1453435 A2 EP 1453435A2 EP 02784553 A EP02784553 A EP 02784553A EP 02784553 A EP02784553 A EP 02784553A EP 1453435 A2 EP1453435 A2 EP 1453435A2
Authority
EP
European Patent Office
Prior art keywords
composition
thermopolymer
dispersion compound
void
titanium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02784553A
Other languages
German (de)
English (en)
Other versions
EP1453435A4 (fr
Inventor
Anthony Ross
Peter Guagliano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvasive Inc
Original Assignee
Nuvasive Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvasive Inc filed Critical Nuvasive Inc
Priority claimed from PCT/US2002/037541 external-priority patent/WO2003045274A2/fr
Publication of EP1453435A2 publication Critical patent/EP1453435A2/fr
Publication of EP1453435A4 publication Critical patent/EP1453435A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2/4601—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for introducing bone substitute, for implanting bone graft implants or for compacting them in the bone cavity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006—Properties of materials and coating materials
    • A61F2002/30065—Properties of materials and coating materials thermoplastic, i.e. softening or fusing when heated, and hardening and becoming rigid again when cooled
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442—Intervertebral or spinal discs, e.g. resilient
    • A61F2002/444—Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0071—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof thermoplastic

Definitions

  • thermopolymer composition that may be used to fill voids within a human body, including but not limited to orthopedic joints (i.e. the discs of the spine and joints of the extremities), spaces between bone fractures or separations, and/or voids created within muscle and/or viscera for the purpose of tissue augmentation. More particularly, the thermopolymer composition of the present invention may be heated and injected into the body in flowable form and thereafter cooled to body temperature to become a flexible, yet relatively solid material.
  • Voids may occur in the body, either through natural causes, injury or medical procedures.
  • void means any space or gap existing between and/or within biologic structures within a body, including but not limited to structures forming part or a portion of orthopedic joints, bones, muscle and/or viscera.
  • excessive wear may cause a void in an orthopedic joint
  • a broken bone may result in gaps in the fracture site
  • arthoscopic surgery may require removing bone or cartilage
  • tissue augmentation may require injecting a compound into muscle and/or viscera and thereby create a void.
  • it may be useful to fill the void with a resilient, non-dispersing material.
  • the void it is desirable to fill the void with a composition that is physiologically acceptable to the human body, and which allows the area to retain normal function and characteristics.
  • proper joint function includes cushioning the forces on the joint and minimizing wear and abrasion to the joint
  • the material, when set, should therefore be resilient, pliable, and non- dispersing.
  • United States Patents 6,183,518, 6,206,921, and 6,264,659 disclose processes for which the present invention may be useful. These patents describe a process for repairing intervertebral disks of mammals by removing nucleus pulposis and injecting a resilient, pliable, non-dispersing material in its place. The present invention may be used with the technology disclosed in these patents to provide an improved resilient, non-dispersing material for filling the void created by removal of the nucleus pulposis and surrounding tissues.
  • One component of a resilient, non-dispersing material may include an isoprene powder, such as gutra percha.
  • Gutta percha and other isoprene materials have been used for example, in dental applications.
  • United States Patent 6,126,446 describes a composition comprising gutta percha and other isoprene powders for filling tooth root canals.
  • U.S. Patent No. 4,632,977 offers other filling compositions based on isoprene materials, such as gutta percha.
  • Other patents of interest include U.S. Patent Nos.
  • 5,047,055 disclosing a prosthetic nucleus for a vertebral disc comprised of hydrogel; 5,545,229, disclosing a replacement disc using elastomeric material in its nucleus and annulus; and 5,800,549, disclosing a method and apparatus for injecting an elastic spinal implant into a cavity in a spinal disc so as to treat disc degeneration.
  • the present invention is directed at addressing the need for an improved void- filling composition and eliminating, or at least reducing the effects of, the above- described problems with the prior art.
  • thermopolymer composition and related methods for filling a void within a human body, wherein the thermopolymer composition has improved mechanical and chemical properties, making it stronger, more durable, and more compatible with the human body.
  • the thermopolymer composition of the present invention is suitable for filling any number of voids (which, as used herein, is defined as any space or gap existing between and/or within biologic structures within a human body). These voids may be formed via natural causes, injury, and/or medical procedures and may, by way of example only, include spaces or gaps formed, created and/or otherwise existing within part or a portion of orthopedic joints (i.e.
  • thermopolymer composition of the present invention include, but are not limited to, disc nucleus replacement (following partial or full discectomy), vertebroplasty, and tissue augmentation procedures.
  • tissue augmentation procedures may include any number of restorative and/or reconfiguration procedures, including but not limited to reconstructive facial surgery, breast augmentation, and urinary incontinence treatment (by injecting the thermopolymer composition of the present invention into the urinary sphincter to serve as a bulking agent).
  • the thermopolymer composition includes a thermopolymer matrix having a dispersion compound therein.
  • the thermopolymer matrix may comprise any number of suitable thermopolymer materials capable of being heated and injected in a flowable or molten state into a body (either into an existing void or creating a void) and thereafter cooling to body temperature to become a flexible, yet relatively solid material.
  • the thermopolymer matrix is gutta percha.
  • the thermopolymer matrix may comprise balata, polyisoprene and/or any mixture of gutta percha, balata and or polyisoprene.
  • the dispersion compound may comprise any number compositions having suitable mechanical, chemical, radiopacity, anti- microbial and/or an ⁇ inflammatory characteristics.
  • Dispersion compounds according to the present invention may include, but are not necessarily limited to, titanium (particles or elongate strands), crystalline particles, gold (in any form) and/or any mixture of titanium, crystalline particles, and/or gold.
  • the constituent components cooperate synergistically, lending their individual favorable characteristics to the resulting thermopolymer composition.
  • the favorable characteristics of the thermopolymer matrix may include a relatively low weight, the ability to flow at elevated temperatures, and the ability to conform to a desired shape upon cooling to body temperature.
  • the favorable characteristics of the dispersion compound may include a low reactivity with the human body (i.e., an anti- inflammatory, non-inflammatory and or non-irritating effect), radiopacity for improved X-ray visualization, and (with regard to titanium or other comparatively high density substances) a high strength-to-weight ratio.
  • the thermopolymer composition of this invention incorporates and capitalizes on the favorable properties of both the thermopolymer matrix and the dispersion compound.
  • thermopolymers such as gutta percha have the ability to flow at injection temperatures, and the ability to set in a desired shape when cooled.
  • the thermopolymer of this invention preferably begins to flow above body temperature.
  • the thermopolymer may be mixed with a dispersion compound (such as titanium particles and/or gold) and optionally any desired fillers, heated above body temperature, then injected into the void.
  • the thermopolymer composition will set upon cooling to body temperature, thereby obtaining its resilient, non-dispersing state, and filling the void.
  • It is another object of this invention to provide a void-filling material mat is compatible with the body. Materials that react strongly with the body are prone to degradation, and may also cause an immune response which, in certain instances, causes inflammation.
  • the present invention accomplishes this by providing a dispersion compound comprising titanium and/or gold, both of which are inert compared with other metals and materials. Titanium and gold are therefore less reactive in the body, and less likely to corrode or degrade into substances that might irritate surrounding tissues.
  • thermopolymer provides this superior durability, and even more so when augmented with titanium as a dispersion compound.
  • the void-filling composition is lightweight
  • the ⁇ nopolymers such as gutta percha may constitute a large volume fraction of this composition, and are relatively lightweight As such, with the relative volume of titanium and/or. gold being relatively low (i.e. preferably 5% to 25% by weight relative to the thermopolymer matrix), the weight contribution of the titanium and or gold is also relatively small.
  • the resulting composition is lightweight and is therefore less likely to hinder the mobility of joints, appendages, and other body parts in which it is used.
  • thermopolymer composition in a manner that it easy to store and use.
  • the present invention accomplishes this, according to one embodiment, by housing the thermopolymer composition in a compressible tube.
  • the compressible tube and its contents may be heated above body temperature, such as by using hot water, an oven, or an open flame.
  • a force may then be applied to the wall of the tube to compress the tube and discharge its contents mrough a nozzle.
  • the compressible tube may thereby assist the application of the composition into the void via a small passage creating the opportunity for a large resulting fill.
  • the void-filling composition may be housed n a syringe instead of a compressible tube.
  • the syringe and its contents may be heated above body temperature, such as by using hot water, an oven, or an open flame.
  • a plunger within the syringe may then be depressed, discharging its contents through a nozzle.
  • the syringe like the compressible tube, may thereby assist the application of the composition to the void.
  • the titanium particles may include (but are not necessarily limited to) elongate whiskers and/or structurally advantageous reinforcement configurations such as a triangular shape or profile. Providing the titanium as elongate whiskers or such a triangular configuration may further enhance the physical properties of the void-filling composition, taking advantage of various principles of composite material technology.
  • Figure 1 illustrates a void-filling composition according to a first broad aspect " of the present invention
  • Figure 2 illustrates a void-filling composition according to a second broad aspect of the present invention
  • Figure 3 illustrates a compressible tube for storing and delivering a void-filling composition according to another aspect of the present invention.
  • Figure 4 illustrates a syringe for storing and delivering a void-filling composition according to a still further aspect of the present invention.
  • thermopolymer composition, delivery systems, and related methods disclosed herein boast a variety of inventive features and components that warrant patent protection, both individually and in combination.
  • FIG. 1 illustrates a thermopolymer composition 10 according to a first broad aspect of the present invention.
  • the thermopolymer composition 10 is suitable for filling any number of voids (which, as used herein, is defined as any space or gap existing between and/or within biologic structures within a human body). These voids may be formed via natural causes, injury, and/or medical procedures and may, by way of example only, include spaces or gaps formed, created and/or otherwise existing within part or a portion of orthopedic joints (i.e. the discs of the spine and joints of the extremities), bones, muscle and/or viscera.
  • voids may be formed via natural causes, injury, and/or medical procedures and may, by way of example only, include spaces or gaps formed, created and/or otherwise existing within part or a portion of orthopedic joints (i.e. the discs of the spine and joints of the extremities), bones, muscle and/or viscera.
  • thermopolymer composition of the present invention includes, but are not limited to, disc nucleus replacement (following partial or full discectomy), vertebroplasty, and tissue augmentation procedures.
  • tissue augmentation procedures may include any number of restorative and/or reconfiguration procedures, including but not limited to reconstructive facial surgery, breast augmentation, and urinary incontinence treatment (by injecting the thermopolymer composition of the present invention into the urinary sphincter to serve as a bulking agent).
  • the thermopolymer composition 10 includes a thermopolymer matrix 12 and a dispersion compound 14.
  • the thermopolymer matrix 12 may comprise any number of suitable thermopolymer materials capable of being heated and injected in a flowable or molten state into a body (either into an existing void or creating a void) and thereafter cooling to body temperature to become a flexible, yet relatively solid material. Because the matrix 12 is a thermoplastic polymer, when cooled to body temperature it returns to its solid state with original solid-state mechanical properties.
  • the thermopolymer matrix 12 preferably comprises gutta percha, but may also comprise balata, polyisoprene and/or any mixture of gutta percha, balata and/or polyisoprene.
  • Gutta percha is natural latex obtained from certain evergreen trees of East Asia, and has been used in products such r , golf-ball coverings, surgical appliances, toys, and adhesives.
  • Balata is a natural nibbe obtained from South American trees. Balata, which is sometimes called gutta balata, has propertied similar to those of gutta-percha, and its processing and uses are essentially the same.
  • Polyisoprene, or natural rubber is harvested from the hevea tree, and has been used to make products such as waterproof boots. Polyisoprene can be treated to give it crosslinks, which makes it an even better elastomer.
  • the dispersion compound 14 may comprise any number compositions having suitable mechanical, chemical, radiopacity, anti-microbial and/or anti-inflammatory characteristics.
  • Dispersion compounds 14 according to the present invention may include, but are not necessarily limited to, titanium (particles or elongate strands), crystalline particles, gold (in any form) and/or any r ⁇ ixture of titanium, crystalline particles, and/or gold.
  • the dispersion compound 14 may comprise any number of suitable gold-containing compositions, including but not limited to gold particles, strands, and/or gold compositions used for so-called "gold injections" for the treatment of arthritis.
  • the gold composition forming the dispersion compound 14 may constitute between 1 and 40 percent (and more preferably between 3 and 15 percent) by weight of the thermopolymer composition 10.
  • the dispersion compound 14 may consist of commercially pure titanium or a titamum alloy with comparable or greater mechanical properties.
  • the titanium particles 14 may constitute between 1 and 50 percent by weight of the thermopolymer composition 10.
  • a titanium-based alloy comprising at least 50 percent by weight titanium included within the scope of
  • the titanium particles 14 may be substantially spherical,. with a diameter less than 50 microns. Preferably, the diameter of the titanium particles is less man 20 microns.
  • the "size" of the titanium particles is defined as the approximate or nominal diameter of the particles. A particle size may be chosen small enough that the resulting composition 10 may be a molecular mixture, with favorable properties and shapes inherent thereto, such as superior mixability with the thermopolymer matrix 12 to facilitate physical properties to meet desired strength characteristics.
  • the dispersion compound 14 may also comprise elongate titanium whiskers 24 and/or nano and molecularly formed structures (not shown) added to the thermopolymer matrix 12.
  • the titanium whiskers 24 may change the way the composition 10 behaves in its solid state, such as by increasing the modulus of elasticity or tensile strength of the thermopolymer composition 10.
  • the diameter of the titanium whiskers 24 may be between 1 and 50 microns, and the whisker nominal diameter defines the "size" of the titanium whisker particles.
  • the length of the titanium whiskers 24 may be varied to further control the mechanical properties of the composition 10.
  • the strength of the composition 1 may be greater than if the titanium whiskers 24 are relatively short and distantly spaced.
  • the weight percentage of the titanium whiskers 24 and any additives in composition 10 may be adjusted to optimize the mechanical properties of the composition 10.
  • the optimum length of the titamum whiskers 24 may depend on many factors, including their weight percentage, the part of the body in which the composition 10 will be used, the type of void (i.e. pre- existing, created by an accident or surgery and/or the introduction of the thermopolymer composition 10), as well as the size of the void to be filled.
  • the thermopolymer composition 10 may also include one or more additives, such as fillers (to reduce the amount of other potential more costly materials), supplemental x-ray contrast agents (to make the composition 10 visible by traditional X-ray), medicinal or pharmaceutical substances (such as antibiotics, anesthetics, and/or biologically transitional material to facilitate biocompatibility), waxes and resins (to increase the flow ability of the composition 10), and sealers (to improve the water-resistance of the composition 10).
  • Zinc may also be added, either to the dispersion compound 14, or separately as additional filler particles, and may comprise up to 10 percent by weight of the composition. Additives should be carefully chosen so the composition 10 retains its beneficial properties such as strength, durability, longevity, and compatibility with the body.
  • the weight percentage of the dispersion compound 14, thermopolymer matrix 12, and any additives should be chosen to optimize the overall properties of the composition. For example, by increasing the percentage of dispersion compound 14, the strength of the composition 10 may likewise increase, but the weight may also increase, and the flexibiUty of the composition 10 may decrease.
  • the optimum mix may be determined prior to use of the composition 10, and chosen with respect to a number of factors, including but not limited to the part of the body in which the composition 10 will be used, the type of void (i.e. pre-existing, created by an accident or surgery and or the introduction of the thermopolymer composition 10), as well as the size of the void to be filled.
  • the thermopolymer composition 10 may be stored in a compressible tube 30, as shown in Figure 3.
  • the composition 10 may be heated to its fluid state, then poured or otherwise transferred into the compressible tube 30 via the open port, which is subsequently plugged.
  • the end plug 35 may then be installed into the compressible tube 30, and the composition may be allowed to cool to its solid state.
  • the composition 10 may be reheated t its liquid state from within the compressible tube 30, such as by placing in an oven, in hot water, or over an open flame.
  • the composition 10 may be squeezed from the compressible tube 30, mrough the nozzle 34, by applying a force to the tube wall 32.
  • the force may be applied to the tube wall 32 either by hand or through, mechanical means, such as by using a spring- biased roller 38.
  • the compressible tube 30 may also facilitate the filling the void by transporting the composition 10 into the void.
  • the composition 10 may instead be stored in a syringe 40, as shown in Figure 4.
  • the composition 10 may be heated to its fluid state, then poured or otherwise transferred into a body 42 of the syringe 40.
  • the composition 10 may then be allowed to cool to its solid state.
  • the composition 10 may be reheated to its liquid state from within the syringe 40, such as by placing in an oven, in hot water, or over an open flame.
  • the composition 10 may then be expelled from the syringe 40, through the nozzle 44, by sliding the plunger 46 relative to the body 42 and toward the nozzle 44.
  • a finger stop 48 may be secured to the body 42, such that the body 42 may be held in place while the plunger 47 is depressed.
  • the first and second fingers of one hand may grab the finger stop 48, while the thumb of that hand depresses the plunger 47.
  • the syringe 40 may also facilitate filing the void by transporting the composition 10 into the void.
  • the thermoplastic composition 10 may be sterilized before use so as to minimize, if not eliminate, the risk of infecting the patient that may otherwise occur with the introduction of non-sterile compositions during the process of void-filling according to the present invention.
  • sterilization techniques may include, but are not necessarily limited to, the application of gamma irradiation to the thermopolymer composition 10 (such as on the order of between 25 to 40 kiloGray). Such irradiation may take place after the formation of the thermopolymer composition 10 and or after the thermopolymer composition 10 has been introduced into a delivery system such as the compressible tube 30 of FIG. 3 and/or the syringe 40 of FIG. 4.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

L'invention concerne une composition thermopolymère appropriée pour utiliser dans des vides de remplissage à l'intérieur du corps humain, notamment mais non exclusivement, dans des articulations orthopédiques (c.-à-d., les disques intervertébraux et les articulations des extrémités), des espaces entre les fractures ou les séparations osseuses, et/ou les vides créés à l'intérieur du muscle et/ou des viscères en vue d'une augmentation de tissus. La composition thermopolymère de la présente invention peut être chauffée et injectée dans le corps sous forme fluide puis refroidie à la température corporelle de façon à devenir un matériau flexible tout en étant relativement solide.
EP02784553A 2001-11-21 2002-11-21 Composition thermopolymere et procedes associes Withdrawn EP1453435A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99071401A 2001-11-21 2001-11-21
US990714 2001-11-21
PCT/US2002/037541 WO2003045274A2 (fr) 2001-11-21 2002-11-21 Composition thermopolymere et procedes associes

Publications (2)

Publication Number Publication Date
EP1453435A2 true EP1453435A2 (fr) 2004-09-08
EP1453435A4 EP1453435A4 (fr) 2009-02-11

Family

ID=25536466

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02784553A Withdrawn EP1453435A4 (fr) 2001-11-21 2002-11-21 Composition thermopolymere et procedes associes

Country Status (3)

Country Link
EP (1) EP1453435A4 (fr)
JP (1) JP2005510291A (fr)
AU (1) AU2002346488A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160144032A1 (en) * 2013-06-18 2016-05-26 National University Corporation Nagoya University Composition for new bone formation, and new bone formation system
CA2989168C (fr) * 2015-07-01 2024-05-28 Nathan Y. Li Composition de remplissage de traitement de canal pouvant etre sterilisee, points/cones fabriques au moyen de cette composition et procede de sterilisation
FR3053239B1 (fr) * 2016-06-30 2022-02-25 Teknimed Susbtitut osseux et systeme d'injection autonome

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998026814A1 (fr) * 1996-12-17 1998-06-25 Jvs-Polymers Oy Materiau plastifiable pour implant
US6126446A (en) * 1998-04-22 2000-10-03 Roeko Gmbh & Co., Dentalerzeugnisse Composition for filling tooth root canals

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998026814A1 (fr) * 1996-12-17 1998-06-25 Jvs-Polymers Oy Materiau plastifiable pour implant
US6126446A (en) * 1998-04-22 2000-10-03 Roeko Gmbh & Co., Dentalerzeugnisse Composition for filling tooth root canals

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03045274A2 *

Also Published As

Publication number Publication date
AU2002346488A1 (en) 2003-06-10
EP1453435A4 (fr) 2009-02-11
JP2005510291A (ja) 2005-04-21

Similar Documents

Publication Publication Date Title
US20040228898A1 (en) Thermopolymer composition and related methods
Vaishya et al. Bone cement
Frazer et al. PMMA: an essential material in medicine and dentistry
US20050107885A1 (en) Total knee joint mold and methods
US20070179620A1 (en) Method and composition for repair and reconstruction of intervertebral discs and other reconstructive surgery
US8524798B2 (en) Materials and apparatus for in-situ bone repair
JPS6236695B2 (fr)
CA2189643A1 (fr) Systeme de resurfacage d'articulations
EP3713615B1 (fr) Utilisation d'une composition d'implant séché pour préparer une formulation d'implant aqueux injectable
CA2256762A1 (fr) Verre bioactif injectable dans une suspension de dextran
US20100292803A1 (en) Compositions and methods for forming and clinically utilizing articulating spacing devices
AU2020292778B2 (en) Injectable aqueous implant formulation containing ascorbic acid
EP1453435A2 (fr) Composition thermopolymere et procedes associes
Baxter et al. The use of polymethyl methacrylate (PMMA) in neurosurgery
Imamura et al. Titania‐containing bioactive bone cement for total hip arthroplasty in dogs
EP1223991B1 (fr) Dispositif medical invasif pouvant etre guide afin de regenerer des tissus
RU2793772C2 (ru) Высушенная композиция импланта и инъектируемый водный состав импланта для инъекции
Christensen et al. Commentary on “Late complications after application of polyacrylamide hydrogel” by Evstatiev

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040603

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVASIVE, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20090114

RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 27/44 20060101ALI20090108BHEP

Ipc: C08L 91/06 20060101ALI20090108BHEP

Ipc: C08L 7/00 20060101ALI20090108BHEP

Ipc: C08K 3/08 20060101ALI20090108BHEP

Ipc: C08J 5/10 20060101ALI20090108BHEP

Ipc: A61K 6/10 20060101ALI20090108BHEP

Ipc: A61F 2/00 20060101AFI20040722BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVASIVE, INC.

17Q First examination report despatched

Effective date: 20090706

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091117